Min Kim
Msc, PhD
Min received a MSc in Pharmaceutical Science and Quality Control in 2012 and a PhD in Metabolomics in 2018, both from King’s College London. His previous research involved metabolomics analytical method developments and identification of dysregulated metabolic pathways in fatty liver disease in adult and children, Type 2 diabetes and Alzheimer’s disease. Since 2021, he works in the metabolomics group at COPSAC, looking at how metabolic profile changes during pregnancy and how these changes are reflected on offsprings’ metabolic profile during their first 6 years.
